Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Alumis Inc. Common Stock

ALMSNASDAQ
Healthcare
Biotechnology
$26.32
$1.51(6.09%)
U.S. Market opens in 7h 6m

Alumis Inc. Common Stock (ALMS) Stock Overview

Explore Alumis Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio-11.15
EPS (TTM)$-2.86
ROE-0.73%
Fundamental Analysis

AI Price Forecasts

1 Month$33.98
3 Months$50.34
1 Year Target$11.05

ALMS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alumis Inc. Common Stock (ALMS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.15 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.05%
5-Day Change
5.92%
1-Month Change
-12.24%
3-Month Change
139.84%
6-Month Change
549.63%
Year-to-Date (YTD) Change
193.64%
1-Year Change
434.76%
3-Year Change
97.82%
5-Year Change
97.82%
All-Time (Max) Change
97.82%

Contact Information

(650) 231-6625
280 East Grand Avenue, South San Francisco, CA, 94080

Company Facts

1,680 Employees
IPO DateFeb 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions